Manufacturing Companies in California
A Biotech company's products or services use biotechnology methods for their creation, fabrication or transfer. It is considered to be the next big thing after the Silicon Valley's revolution.
Manufacturing Companies in California
Biotech Companies in California: Fertile Ground
By Jeremy B Thompson
A Biotech company's products or services use highly technological methods for their creation, fabrication and transfer. This new industry is considered to be the next big thing after the Silicon Valley revolution.
The last 30 years in biotech can be considered a time of energetic growth and incomparable discovery. This is especially true for the biotech companies in California, since 40 percent of all public biotech companies in the nation are there. The total revenue of this industry was $40 billion in 2003. Pharmaceutical companies and venture capitalists alike have taken notice of this fact in the last few years.
California's excellent research universities positioned the state at the vanguard of this revolution. Institutions such as the California NanoSystems Institute and the Joint Genomics Institute lead the way. And the founders of biotech companies are mostly professors of the aforementioned California educational institutes. It is not surprising that the Golden State is often mentioned as the home base or birthplace of the U.S. biotech industry.
This industry is knowledge-intensive and attracts a great deal of venture capital and investments from the pharmaceutical giants. Generally biotech companies in California need lots of capital at all stages of development. They need between $250 million and $500 million to finance growth until profitability.
The cycle of research, product development, clinical or even field trials (if necessary), and manufacturing is not a cheap process. Still, it is well-known that investments made in this industry are considered a high-reward component of any robust investment portfolio. This is evidenced by the fact that the investments made by pharmaceutical companies or venture capitalists are still coming in even in these difficult times. Naturally, this will happen just to the biotech firms with strong business and effective plans. Due to this, many a California biotech companies seek out a very special niche industry space where the profit is achievable, to become more attractive for investment.
The basic characteristic of a venture capital investment is that it is the most active type of investing there is. Once a biotech firm has a "smash hit" product in the market, the venture capitalist will jump at the chance to make a huge profit.
Besides the average venture capitalist, pharmaceutical companies have the strongest impact as investors. However, their reason to make an investment can be to form a special team for their own needs. Often, they buy entire companies. One example of their reach came in 1995 when big pharma invested $4.5 billion in California biotech companies alone.
By Jeremy B Thompson
A Biotech company's products or services use highly technological methods for their creation, fabrication and transfer. This new industry is considered to be the next big thing after the Silicon Valley revolution.
The last 30 years in biotech can be considered a time of energetic growth and incomparable discovery. This is especially true for the biotech companies in California, since 40 percent of all public biotech companies in the nation are there. The total revenue of this industry was $40 billion in 2003. Pharmaceutical companies and venture capitalists alike have taken notice of this fact in the last few years.
California's excellent research universities positioned the state at the vanguard of this revolution. Institutions such as the California NanoSystems Institute and the Joint Genomics Institute lead the way. And the founders of biotech companies are mostly professors of the aforementioned California educational institutes. It is not surprising that the Golden State is often mentioned as the home base or birthplace of the U.S. biotech industry.
This industry is knowledge-intensive and attracts a great deal of venture capital and investments from the pharmaceutical giants. Generally biotech companies in California need lots of capital at all stages of development. They need between $250 million and $500 million to finance growth until profitability.
The cycle of research, product development, clinical or even field trials (if necessary), and manufacturing is not a cheap process. Still, it is well-known that investments made in this industry are considered a high-reward component of any robust investment portfolio. This is evidenced by the fact that the investments made by pharmaceutical companies or venture capitalists are still coming in even in these difficult times. Naturally, this will happen just to the biotech firms with strong business and effective plans. Due to this, many a California biotech companies seek out a very special niche industry space where the profit is achievable, to become more attractive for investment.
The basic characteristic of a venture capital investment is that it is the most active type of investing there is. Once a biotech firm has a "smash hit" product in the market, the venture capitalist will jump at the chance to make a huge profit.
Besides the average venture capitalist, pharmaceutical companies have the strongest impact as investors. However, their reason to make an investment can be to form a special team for their own needs. Often, they buy entire companies. One example of their reach came in 1995 when big pharma invested $4.5 billion in California biotech companies alone.
Interested in biotech companies in California? Visit our California biotech conference website to learn how you can engage in this vital industry segment.
No comments:
Post a Comment